![Servier - Moved by you..]({"type":"image" , "src" : "/sda/112354/JournalAd-Servier-5s.gif"})
References
- Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocar-dium. Circulation 1986, 74: 1124–36.
- Murphy E. Primary and secondary signaling pathways in early preconditioning that converge on the mitochondria to produce cardioprotection. Circ Res 2004; 94: 7–16.
- Ardehali H, O'Rourke B. Mitochondrial KATP channels in cell survival and death. J Mol Cell Cardiol 2005; 39: 7–16.
- van den Bosch BJ, van den Burg CM, Schoonderwoerd K, Lindsey PJ, Scholte HR, de Coo RF, van Rooij E, Rodman HA, Doevendans PA, Smeets HJ. Regional absence of mito-chondria causing energy depletion in the myocardium of mus-cle LIM protein knockout mice. Cardiovasc Res 2005; 65: 411–8.
- Flameng W, Borgers M, Daenen W, Stalpaert G. Ultrastruc-tual and cytochemical correlates of myocardial protection by cardiac hypothermia in man. J Thorac Cardiovasc Surg 1980; 79: 413–24.
- Garlid KD, Paucek P, Yarov-Yarovoy V, Murray HN, Dar-benzio RB, D'Alonzo AJ, Lodge NJ, Smith MA, Grover GJ. Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Circ Res 1997; 81: 1072–82.
- Wang S, Cone J, Liu Y. Dual roles of mitochondrial K(ATP) channels in diazoxide-mediated protection in isolated rabbit hearts. Am J Physiol Heart Circ Physiol 2001; 280: H246–55.
- Korge P. Honda HM, Weiss JN. Protection of cardiac mito-chondria by diazoxide and protein kinase C: implicationsfor ischemic preconditioning. Proc Natl Acad Sci U S A, 2002; 99: 3312–7.
- Nisoli E, Carruba MO. Nitric oxide and mitochrondrial biogenesis. J Cell Sci 2006; 119 (Pt 14): 2855–62.
- Puigserver P, Spiegelman BM. Peroxisome proliferator-activated receptor-y coactivator 1 alpha (PGC-1a): transcrip-tional coactivator and metabolic regulator. Endocr Rev 2003, 24: 78–90.
- St-Pierre J, Lin J, Krauss S, Tarr PT, Yang R, Newgard CB, Spiegelman BM. Bioenergetic analysis of peroxisome pro-liferator-activated receptor gamma coactivators 1 apha and lbeta (PGC-1 alpha and PGC-1 beta) in muscle cells. J Biol Chem 2003; 278: 26597–603.
- Leone TC, Lehman JJ, Finck BN, Schaeffer PJ, Wende AR, Boudina S, Courtois M, Wozniak DF, Sambandam N, Bernal-Mizrachi C, Chen Z, Holloszy JO, Medeiros DM, Schmidt RE, Saffitz JE, Abel ED, Semenkovich CF, Kelly DP. PGC-1 alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight I/R and hepatic steatosis. PLoS Biol 2005; 3: el01.
- Kelly DP, Scarpulla RC. Transcriptional regulatory circus controlling mitochondrial biogenesis and function. Genes Dev 2004; 18: 357–68.
- Vimaleswaran KS, Radha V, Ghosh S, Majumder PP, Deepa R, Babu HNS, Rao MRS, Mohan V. Peroxisome prolifera-tor-activated receptor-y coactivator-la (PGC-1a) gene poly-morphisms and their relationship to type 2 diabetes in Asian Indians. Diabetic Med 2005; 22: 1516–21.
![Committed to improving the lives of patients with Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.]({"type":"image" , "src" : "/sda/112387/JournalAd-TACD-BOEHR-MPU.jpg"})
![Novartis. Your partner in Heart Failure & Atherosclerosis >>]({"type":"image" , "src" : "/sda/112381/JournalAd-TACD-Novartis-Skyscraper.jpg"})